Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Sasaki

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Plos One|September 12, 2024
Implementation status of postoperative rehabilitation for older patients with hip fracture in Kyoto City, Japan: A population-based study using medical and long-term care insurance claims dataKosuke Sasaki, Yoshimitsu Takahashi, Mayumi Toyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[The Different Indications and Treatment Effect between Preoperative Chemotherapy and Preoperative Radiotherapy for Advanced Rectal Cancer]Nobuhiro Takiguchi, Hiroaki Souda, Toru Tonooka, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 2, 2021
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancerReiri Shimazaki, Shigetsugu Takano, Mamoru Satoh, et al.
Scientific Reports|October 10, 2020
Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureusTanit Boonsiri, Shinya Watanabe, Xin-Ee Tan, et al.
Journal of Medicinal Chemistry|July 7, 2017
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.
Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Plos One|September 12, 2024
Implementation status of postoperative rehabilitation for older patients with hip fracture in Kyoto City, Japan: A population-based study using medical and long-term care insurance claims dataKosuke Sasaki, Yoshimitsu Takahashi, Mayumi Toyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[The Different Indications and Treatment Effect between Preoperative Chemotherapy and Preoperative Radiotherapy for Advanced Rectal Cancer]Nobuhiro Takiguchi, Hiroaki Souda, Toru Tonooka, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 2, 2021
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancerReiri Shimazaki, Shigetsugu Takano, Mamoru Satoh, et al.
Scientific Reports|October 10, 2020
Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureusTanit Boonsiri, Shinya Watanabe, Xin-Ee Tan, et al.
Journal of Medicinal Chemistry|July 7, 2017
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.
Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.
Pageof 6